113 related articles for article (PubMed ID: 8910512)
1. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity.
Sala A; De Luca A; Giordano A; Peschle C
J Biol Chem; 1996 Nov; 271(46):28738-40. PubMed ID: 8910512
[TBL] [Abstract][Full Text] [Related]
2. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
3. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells.
Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C
J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601
[TBL] [Abstract][Full Text] [Related]
4. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
5. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
6. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
Pilkinton M; Sandoval R; Colamonici OR
Oncogene; 2007 Nov; 26(54):7535-43. PubMed ID: 17563750
[TBL] [Abstract][Full Text] [Related]
10. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
11. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the cell cycle by B-Myb.
Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the murine surfactant protein-A gene by B-Myb.
Bruno MD; Whitsett JA; Ross GF; Korfhagen TR
J Biol Chem; 1999 Sep; 274(39):27523-8. PubMed ID: 10488087
[TBL] [Abstract][Full Text] [Related]
14. B-myb rescues ras-induced premature senescence, which requires its transactivation domain.
Masselink H; Vastenhouw N; Bernards R
Cancer Lett; 2001 Sep; 171(1):87-101. PubMed ID: 11485831
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
[TBL] [Abstract][Full Text] [Related]
16. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein.
Seong HA; Kim KT; Ha H
J Biol Chem; 2003 Mar; 278(11):9655-62. PubMed ID: 12645566
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulation of E2F site occupation in vivo.
Zwicker J; Liu N; Engeland K; Lucibello FC; Müller R
Science; 1996 Mar; 271(5255):1595-7. PubMed ID: 8599118
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
[TBL] [Abstract][Full Text] [Related]
20. Transcription regulation by murine B-myb is distinct from that by c-myb.
Watson RJ; Robinson C; Lam EW
Nucleic Acids Res; 1993 Jan; 21(2):267-72. PubMed ID: 8382794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
